Cargando...
Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of non-homologous end joining
The combination of cisplatin and ionizing radiation treatment represents a common modality for treating a variety of cancers. These two agents provide considerable synergy during treatment although the mechanism of this synergy remains largely undefined. We have investigated the mechanism of cisplat...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2005
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2432110/ https://ncbi.nlm.nih.gov/pubmed/15886299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-04-0032 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|